Overview

Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects

Status:
Completed
Trial end date:
2023-11-29
Target enrollment:
Participant gender:
Summary
The study aimed to assess the effects of omeprazole on single-dose SHR2554 in healthy subjects, exploring the pharmacokinetic changes of SHR2554 and ensuring the safety when SHR2554 is co-administered with omeprazole.
Phase:
Phase 1
Details
Lead Sponsor:
Jiangsu HengRui Medicine Co., Ltd.
Treatments:
Omeprazole